U.S. Electrical Stock News

Meritage Homes (MTH) has just laid out a fresh set of numbers for Q1 2026 against a backdrop where trailing twelve month revenue sits at about US$5.9b and basic EPS for the same period is US$6.40, with trailing net margin of 7.7% versus 12.3% a year earlier. Over the last reported quarters, revenue in individual periods has ranged from US$1.36b to US$1.63b while basic EPS has moved between US$1.21 and US$2.71. This gives investors a clear view of how top line scale and per share earnings have...

If you are wondering whether Everest Group at US$350.81 is offering fair value or a potential bargain, the key is to look past the headline price and into how it stacks up on several valuation checks. Over shorter periods the stock has had mixed results, with returns of 1.9% over 7 days, 8.4% over 30 days, 4.9% year to date, 1.2% over 1 year, flat over 3 years and 43.5% over 5 years. This may have shifted how investors view its growth potential and risk. Recent coverage has focused on...

If you are wondering whether Concentrix at around US$26.78 is a bargain or a value trap, the key lies in understanding how its current price lines up with different valuation checks. The stock has seen a 9.5% decline over the last 7 days, sits roughly flat over 30 days with a 1.1% gain, and is still showing heavier falls of 35.0% year to date and 45.3% over the past year. Those moves come after a much longer slide, with 3 year returns of 70.1% and 5 year returns of 81.6%. This keeps many...

Recent trading context for Sila Realty Trust Sila Realty Trust (SILA) has drawn fresh attention after a recent move in its share price, with the stock last closing at $30.40 and showing double digit returns over the past month. For investors watching healthcare focused real estate, the trust’s recent share performance, its US$1.68b market value and current financial profile provide a starting point for assessing how its net lease model fits into a diversified income portfolio. See our latest...

If you are wondering whether Ionis Pharmaceuticals at around US$74.09 is priced for more growth or already reflects the story, the key is to look carefully at what the current valuation actually implies. The stock has had a mixed recent run, with a 1.6% decline over the last 7 days, a 6.3% gain over the past month, a 7.0% decline year to date, and a 150.6% return over the last year that may have reshaped expectations and perceived risk. Recent coverage around Ionis has focused on its...

Louisiana-Pacific (NYSE:LPX) announced a new partnership with the Ruffed Grouse Society and American Woodcock Society to support sustainable forest management and wildlife habitat projects in the Upper Midwest. The collaboration focuses on working with private landowners to improve ecological outcomes and help support long term wood fiber supply for the company. For investors tracking NYSE:LPX, this environmental partnership arrives with the stock at $74.7 and a value score of 1. The share...

Liberty Energy (LBRT) has put fresh numbers on the table for Q1 2026, with revenue of $1.0b, basic EPS of $0.14 and net income of $22.6 million setting the tone for the latest update. Over the past year, the company has seen quarterly revenue move between $943.6 million and $1.0b while basic EPS has ranged from $0.08 to $0.44. This gives investors a clearer view of how the top line and per share earnings have tracked into the current print. With revenue still presented in the context of...

CACI International Q3 2026 earnings in focus CACI International (CACI) has just posted Q3 2026 results with revenue of US$2.4b and basic EPS of US$5.90, alongside trailing twelve month revenue of US$9.2b and EPS of US$24.36 that sit against a net profit margin of 5.9%. Over recent quarters the company has seen revenue move from US$2.17b in Q3 2025 to US$2.35b in Q3 2026, while quarterly EPS has ranged from US$5.02 to US$7.18 across that period. This gives investors a clearer view of how...

Wondering whether Green Brick Partners at around US$71.84 is still offering value, or if most of the upside is already reflected in the share price. The stock has logged returns of 9.4% over 7 days, 13.6% over 30 days, 13.7% year to date and 23.9% over the last year, with longer term figures of 95.0% over 3 years and 170.3% over 5 years giving extra context to the recent move. Recent attention around Green Brick Partners has focused on the homebuilding space, with investors weighing how...

If you are wondering whether CRA International at around US$150 a share looks attractively priced or fully valued, you are not alone. The stock has seen a 7.4% decline over the last week, a 5.0% decline over the last month and a 25.1% decline year to date, even though the 3 year and 5 year returns stand at 49.5% and 98.7% respectively. Recent attention on CRA International has focused on its long term share price record and how that compares with the more muted 1 year return of a 6.5%...

Selective Insurance Group (SIGI) has just posted another quarter of solid headline numbers, with Q4 2025 revenue at US$1.4b and net income of US$152.9m translating into basic EPS of US$2.52. This sets the stage for how you read the upcoming Q1 2026 update. Over the last year, revenue has moved from US$1.3b in Q1 2025 to US$1.4b in Q4 2025, while trailing twelve month EPS reached US$7.54 on net income of US$457.2m. This gives you a clearer picture of how the earnings base feeding into the...

Brown-Forman (NYSE:BF.B) is reported to be in ongoing takeover discussions involving both Sazerac and Pernod Ricard. The parties are said to be exploring different deal structures, including full acquisition and potential combinations of assets or joint arrangements. These talks focus on control of Brown-Forman's portfolio of spirits brands and its long established presence in the global alcohol market. Brown-Forman is a major producer of spirits, with brands that are well known to...

Wondering whether Nuvation Bio at around US$5.04 is offering genuine value or just riding on excitement? This article breaks down what the current share price may be implying about the business. The stock has returned 4.8% over the last 7 days and 17.8% over the last 30 days, while year to date it is down 41.3% and the 1 year return sits at 136.6%, with a 3 year return of 217.0% and a 5 year return of 56.5%. Recent price action has come alongside ongoing interest in the company’s drug...

Tri Pointe Homes amended its credit agreement to address lender terms related to its pending merger with Sumitomo Forestry. The amendment updates change in control provisions that could have affected the transaction. This move represents another formal step toward closing the merger between Tri Pointe Homes and Sumitomo Forestry. For investors watching NYSE:TPH, the amended credit agreement comes as the stock trades at $46.89 and has logged a 48.5% return year to date and 51.9% over the...

If you are wondering whether Atmos Energy at around US$187.81 is still reasonably priced or already baking in a lot of optimism, the valuation picture is worth a closer look. The stock has returned 3.4% over the last 30 days and 10.9% year to date, while the 1 year and 5 year returns sit at 20.2% and 108.2% respectively, which may have shifted how the market views its risk and reward balance. Recent coverage has focused on Atmos Energy as a regulated gas utility with ongoing investment in...

Nano-X Imaging’s April 2026 update showed fourth-quarter 2025 sales rising to US$3.72 million while net loss widened to US$33.37 million, including a US$17.53 million impairment, alongside full-year 2025 losses and the appointment of incoming CFO Guy Nathanzon after Ran Daniel’s planned departure. At the same time, a new clinical collaboration with Meir Medical Center to further validate the Nanox.ARC system highlights management’s focus on strengthening the technology’s real-world...

Sprinklr (NYSE:CXM) has launched its Spring 2026 Release, introducing advanced AI-driven features for its customer experience platform. The release adds autonomous agent evaluation tools designed to assess and monitor AI performance in customer service. Sprinklr also announced a new alliance with CreatorIQ to integrate creator intelligence with its unified social media management capabilities. Sprinklr enters this product release cycle with its shares at $4.84 and a value score of 2,...

ZORYVE (roflumilast) cream has received a strong, high certainty recommendation in the American Academy of Dermatology’s new pediatric atopic dermatitis guidelines. This is the AAD’s first set of clinical practice guidelines focused on pediatric atopic dermatitis, giving the product formal visibility in a key treatment area. The endorsement supports ZORYVE’s role as an evidence backed option for long term use in children with atopic dermatitis. For Arcutis Biotherapeutics (NasdaqGS:ARQT),...

Popular (BPOP) has just posted another solid quarter, with Q4 2025 revenue of US$751.8 million and basic EPS of US$3.54, setting the tone as investors look at the new Q1 2026 reporting period. The bank has seen quarterly revenue move from US$689.4 million in Q4 2024 to US$751.8 million in Q4 2025, while basic EPS over that same stretch climbed from US$2.51 to US$3.54, giving you a clear sense of how the income line has scaled alongside the top line. Taken together with an improved net profit...

American Riviera Bancorp (ARBV) opened 2026 with Q1 results that build on a solid finish to last year, with Q4 2025 revenue at about US$14.4 million and basic EPS of roughly US$0.80, while trailing twelve month revenue stood at about US$50.4 million and EPS at roughly US$2.18. Over recent quarters, revenue has moved from about US$10.7 million in Q4 2024 to US$14.4 million in Q4 2025, and basic EPS has shifted from roughly US$0.35 to US$0.80. This sets up a story where higher net income and...

Mesabi Trust (MSB) has put fresh FY 2026 numbers on the table, with third quarter revenue of US$3.6 million, basic EPS of US$0.21 and net income of US$2.8 million. The trust has seen quarterly revenue move between US$4.7 million and US$6.9 million and EPS range from US$0.28 to US$0.46 over the past year of reported periods, alongside net income between US$3.6 million and US$6.1 million. This sets a clear context for the latest print. With a trailing net margin of 82.8% and earnings quality...

Farmers & Merchants Bancorp (FMAO) has put fresh numbers on the board, with Q4 2025 revenue of about US$31.9 million and basic EPS of US$0.70, supported by net income of US$9.7 million as the latest marker ahead of its Q1 2026 reporting period. The business has seen revenue move from US$26.6 million and EPS of US$0.59 in Q4 2024 to US$31.9 million and EPS of US$0.70 in Q4 2025. Trailing 12 month earnings growth of 29.4% and a 27.6% net margin frame a profitability profile that many investors...

Southern Missouri Bancorp (SMBC) opened Q3 2026 with Q2 results that put revenue and earnings in clear focus, reporting total revenue of US$48.0 million and basic EPS of US$1.62 on net income of US$18.1 million. The company has seen revenue move from US$41.7 million with EPS of US$1.10 in Q1 2025 to US$45.1 million and EPS of US$1.40 in Q4 2025, then to US$48.0 million and EPS of US$1.62 in Q2 2026. This latest report can be viewed as part of a steady earnings story that investors can now...

QCR Holdings (QCRH) just wrapped up Q1 2026 with recent quarterly revenue running around US$101.5 million and basic EPS of about US$2.13, backed by trailing twelve month revenue of roughly US$351.5 million and EPS of US$7.54 that has been associated with an 11.7% earnings growth rate over the past year. Over recent periods, the company has seen revenue move from US$330.2 million and EPS of US$6.77 on a trailing basis in Q4 2024 to US$351.5 million and EPS of US$7.54 by Q4 2025, supported by a...